Term and Termination. 12.1 This Agreement shall become valid and effective on the date of signing by the duly authorised representatives of both Parties (i.e. by all participants of the Agreement).
Term and Termination. This Agreement is being entered into for an indefinite term. Hence, and for the avoidance of doubt, the Credit Agreement shall cover all Credit drawn down by you during its validity and shall continue to apply with respect to any and all outstanding amounts due hereunder.
Term and Termination. This EULA shall remain effective until terminated or until the expiration of the applicable license or subscription term. You may terminate the EULA at any time by ceasing use of or destroying all copies of Software. This EULA will immediately terminate if You breach its terms, or if You fail to pay any portion of the applicable license fees and You fail to cure that payment breach within thirty (30) days of notice. Upon termination of this EULA, You shall destroy all copies of Software in Your possession or control.
Term and Termination a) Term. Subject to Customer’s payment of Fees, the rights granted by Revolgy in this Agreement will continue for the Term, unless terminated earlier as set out in this Agreement. At the end of the Initial Term, the Agreement will automatically renew for consecutive terms of twelve months (each a “Renewal Term”), unless either party provides the other party with written notice of its decision not to renew at least 30 days prior to the end of the then-current Initial Term or Renewal Term (as applicable).
b) Change of Control. If a party experiences a change of control (for example, through a stock purchase or sale, merger, or other form of corporate transaction): (a) that party will give written notice to the other party within 30 days after the change of control; and (b) the other party may immediately terminate this Agreement any time between the change of control and 30 days after it receives that written notice.
c) Material Breach and Insolvency. Either party may immediately terminate this Agreement if: (i) the other party is in material breach of this Agreement and, if the breach is remediable, fails to remedy that breach within thirty days after receipt of written notice; (ii) the other party enters into an arrangement or composition with or for the benefit of its creditors, goes into administration, receivership or administrative receivership, or is dissolved or otherwise ceases its business operations or becomes subject to insolvency or bankruptcy proceedings and the proceedings are not dismissed within ninety days; or (iii) the other party is in material breach of this Agreement more than twice notwithstanding any remedy of such breaches. Where Revolgy has the right to terminate this Agreement under this Clause, Revolgy may choose to suspend or terminate any, all, or any part of the Services or Projects. Besides, Services may be terminated in case when the Customer engages in illegal or deceptive trade practices or any other behaviour prohibited by this Agreement.
Term and Termination. 12.1 Without prejudice to any rights or remedies which the parties may have against each other or to any other provision of this Agreement, this Agreement may be terminated: by either party at any time by giving sixty (60) days prior written notice to the other party; or
Term and Termination. (a) Term. Unless terminated sooner in accordance with Section 5(b), this Agreement shall continue in effect for an initial term of twelve (12) months from the Service Date (the “Initial Term”). Licensee may renew the Agreement for additional twelve (12)-month periods, unless otherwise specified, (each, a “Renewal Term”) upon written notice to IEEE and payment of the annual license fee, as determined by IEEE, within thirty (30) days prior to the expiration of the Initial Term or any Renewal Term. In the event that Licensee elects to not renew, Licensee shall notify IEEE at least thirty (30) days prior to the Renewal Term.
(b) Termination. Notwithstanding the terms of Section 5(a), this Agreement may be terminated as follows:
(1) Material Breach. Either party may terminate this Agreement in the event of a material breach by the other party that remains uncured thirty (30) days after the non-breaching party gives the breaching party written notice of such breach.
(2) Suspension. In the event that IEEE notifies Licensee of a material breach of Section 3(c)(1), IEEE reserves the right to suspend Licensee’s access to the Licensed Products. IEEE will make commercially reasonable efforts to limit suspension to the offending IP address or user account, to the extent that the offending IP address or user account can be reasonably ascertained under the circumstances; otherwise, IEEE reserves the right to suspend all online access to the Licensed Products by Licensee. The suspension shall remain in effect until Licensee has cured the material breach, and Licensee shall not be entitled to a refund of any fees during such suspension. If Licensee does not cure the material breach within thirty (30) days after notice of such breach, IEEE shall be entitled to terminate this Agreement immediately.
Term and Termination. 12.1 Without prejudice to any rights or remedies which the parties may have against each other or to any other provision of this Agreement, this Agreement may be terminated:
a) by either party at any time by giving sixty (60) days prior written notice to the other party; or
b) immediately upon written notice by either
c) okamžitě poté, co kterákoli ze smluvních stran písemně uvědomí druhou smluvní stranu v případě, že se druhá smluvní strana ocitne v Platební neschopnosti.
12.2 Po ukončení této Smlouvy se Kupující zavazuje uhradit všechny částky dlužené společnosti Amgen v plné výši, a to do třiceti (30) dnů od data ukončení Smlouvy.
12.3 Jestliže má společnost Amgen v dobré víře za to, že finanční situace Kupujícího se od data uzavření této Smlouvy významně zhoršila, může společnost Amgen bez újmy na jakémkoli jiném právu nebo opravném prostředku, které má k dispozici, a za podmínek dodržení všech příslušných zákonů, pozastavit dodávky a požadovat úplnou nebo částečnou úhradu předem nebo party to the other in the event of the other party committing any breach of this Agreement which is not remedied within thirty (30) days of written notice from the first party requiring such remedy; or
c) immediately upon either party giving written notice to the other if an Insolvency Event occurs in respect of the other party.
12.2 Upon termination of this Agreement, Buyer shall pay all amounts owing to Amgen in full within thirty (30) days of the date of such termination.
12.3 If Amgen in good faith considers that financial condition of Buyer has significantly deteriorated from the date of this Agreement, Amgen may, without prejudice to any other right or remedy available to it and subject to all applicable laws, suspend delivery and require full or partial payment in advance or demand security for payment as a condition of continuing delivery. Upon Amgen's reasonable request therefore, Buyer shall provide to
Term and Termination. The term of this Agreement shall commence on the date You first accept this Agreement in the Service and extend for an initial period of one (1) year following the initial activation date of Your Service account by Apple. Thereafter, subject to Your compliance with the terms of this Agreement, the term of this Agreement will automatically renew for successive one (1) year terms, unless sooner terminated in accordance with this Agreement. Either party may terminate this Agreement for its convenience, for any reason or no reason, effective 30 days after providing the other party with written notice of its intent to terminate. If You fail, or Apple suspects that You have failed, to comply with any of the provisions of this Agreement, Apple, at its sole discretion, without notice to You may: (a) terminate this Agreement and/or Your account; and/or (b) suspend or preclude access to the Service (or any part thereof). Apple reserves the right to modify, suspend, or discontinue the Service (or any part or content thereof) at any time without notice to You, and Apple will not be liable to You or to any third-party should it exercise such rights. Apple may also terminate this Agreement, or suspend Your rights to use the Services, if You fail to accept any new Agreement terms as described in Section 4. You acknowledge and agree that You may not be able to access the Service upon expiration or termination of this Agreement and that Apple reserves the right to suspend access to or delete data or information that You, Your Administrators, Authorized Users, Permitted Entities, or Permitted Users have stored through Your use of the Service. You should review the Documentation prior to using any part of the Service and make appropriate back-ups of Your data and information. Apple will not be liable or responsible to You or to any third party should it exercise such rights or for any damages that may result or arise out of any such termination or suspension. The following provisions shall survive the termination of this Agreement: Section 1, the second sentence of Section 2.9, Section 2.10, the second sentence of Section 2.11, Section 3, Section 5, the second paragraph of Section 6, and Sections 7, 8, 9, and 10.
Term and Termination. This Agreement shall be in effect from January, 1st 2024 until December, 31st 2024 (the “Term”). SAGE may cancel this License with regard to Licensee if Licensee violates any of the terms and conditions set forth herein, including the Confidentiality provision in Section (VI). Thirty (30) days prior to the expiration of the Term, and upon Licensee’s written request, SAGE shall deliver to Licensee the data comprising the volume years January, 1st 2024 until December, 31st 2024 of the Licensed Materials, and the use of such provided material shall be governed by the terms of this License. All information will be delivered in an electronic medium agreed to by the Parties. If Licensee has had its subscription cancelled due to breach it shall not be entitled to access the Licensed Materials or any portion thereof after such cancellation. The terms and conditions of paragraphs 2, 5, 6 and 10 shall survive termination of this license.
Term and Termination. (a) x x x x x
(a) x
(b) Společnost Xxxxxxxx, s písemným oprávněním od Zadavatele, si vyhrazuje právo tuto Smlouvu ukončit:
(i) do třiceti (30) dnů od písemného vyrozumění Zdravotnickému zařízení; nebo
(ii) okamžitě, pokud Zadavatel ukončí Smlouvu o klinickém hodnocení se společností Xxxxxxxx za účelem provedení této Studie; nebo
(iii) pokud se Zkoušejícímu nepodaří provést nábor nebo zapojit do Studie dostatečný počet Subjektů hodnocení pro účast ve Studii za účelem pravděpodobného splnění statistických požadavků platných pro Studii, které byly stanoveny Zadavatelem.
(c) Kterákoli Strana může tuto Smlouvu ukončit po poskytnutí písemného oznámení dané Straně, které nabude okamžité platnosti, pokud
(i) daná Strana poruší jakákoli ustanovení této Smlouvy a takové porušení nebude napraveno během třiceti (30) dní od obdržení písemného oznámení žádající takovou nápravu;
(ii) kterákoli Strana se odůvodněně domnívá, že riziko pro Subjekty hodnocení spojené s pokračováním Studie se stává nepřijatelné z
(b) Xxxxxxxx, with written authorization from Sponsor, reserves the right to terminate this Agreement;
(i) upon thirty (30) days written notice to Institution; or
(ii) upon immediate effect if the Sponsor terminates its clinical research agreement with Xxxxxxxx for the conduct of the Study; or
(iii) if Investigator has failed to recruit or enroll a sufficient number of Study subjects for participation in the Study to make it likely that the statistical requirements applicable to the Study will be met, as determined by Sponsor.
(c) Either Party may terminate this Agreement by written notice to the other Party, which will take effect immediately, if
(i) the other Party breaches any provisions of this Agreement and such breach is not remedied within thirty (30) days of the breaching Party’s receipt of a written notice requesting such a remedy;
(ii) either Party reasonably considers that risk to the Study subjects associated with continuation of the Study becomes